terazosin hydrochloride

Generic: terazosin hydrochloride

Labeler: apnar pharma lp
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin hydrochloride
Generic Name terazosin hydrochloride
Labeler apnar pharma lp
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
Apnar Pharma LP

Identifiers & Regulatory

Product NDC 24689-855
Product ID 24689-855_2d125642-5083-4147-e063-6394a90a329c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074823
Listing Expiration 2026-12-31
Marketing Start 2020-06-30

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24689855
Hyphenated Format 24689-855

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0324689882017 0324689792019 0324689882109 0324689961101 0324689961033 0324689882031 0324689961019 0324689855103 0324689792101 0324689792033 0324689855035 0324689855011
UNII
D32S14F082

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin hydrochloride (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA074823 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (24689-855-01)
  • 90 CAPSULE in 1 BOTTLE (24689-855-03)
  • 1000 CAPSULE in 1 BOTTLE (24689-855-10)
source: ndc

Packages (3)

24689-855-01 100 CAPSULE in 1 BOTTLE (24689-855-01) 24689-855-03 90 CAPSULE in 1 BOTTLE (24689-855-03) 24689-855-10 1000 CAPSULE in 1 BOTTLE (24689-855-10)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Terazosin Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2d125642-5083-4147-e063-6394a90a329c", "openfda": {"upc": ["0324689882017", "0324689792019", "0324689882109", "0324689961101", "0324689961033", "0324689882031", "0324689961019", "0324689855103", "0324689792101", "0324689792033", "0324689855035", "0324689855011"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["a9176551-3da9-34c1-e053-2995a90a3aee"], "manufacturer_name": ["Apnar Pharma LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (24689-855-01)", "package_ndc": "24689-855-01", "marketing_start_date": "20200630"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (24689-855-03)", "package_ndc": "24689-855-03", "marketing_start_date": "20250215"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (24689-855-10)", "package_ndc": "24689-855-10", "marketing_start_date": "20200630"}], "brand_name": "Terazosin Hydrochloride", "product_id": "24689-855_2d125642-5083-4147-e063-6394a90a329c", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "24689-855", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Apnar Pharma LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin Hydrochloride", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA074823", "marketing_category": "ANDA", "marketing_start_date": "20200630", "listing_expiration_date": "20261231"}